Application of recombinase polymerase amplification with lateral flow assay to pathogen point-of-care diagnosis
Frontiers in Cellular and Infection Microbiology · 18.11.2024 · 14
DOI: 10.3389/fcimb.2024.1475922 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 18.11.2024. Verfasst von Yilian Zhao und 7 weiteren Autor:innen. Beteiligte Einrichtung: The First Clinical Medical College of Guangxi Medical University, Nanning, China. Hauptthemen laut MEDLINE: Nucleic Acid Amplification Techniques, Recombinases, Point-of-Care Testing, Molecular Diagnostic Techniques. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Since the outbreak of the new coronavirus, point-of-care diagnostics based on nucleic acid testing have become a requirement for the development of pathogen diagnostics, which require the ability to accurately, rapidly, and conveniently detect pathogens. Conventional nucleic acid amplification techniques no longer meet the requirements for pathogen detection in low-resource, low-skill environments because they require specialist equipment, complex operations, and long detection times. Therefore, recombinant polymerase amplification (RPA) is becoming an increasingly important method in today’s nucleic acid detection technology because it can amplify nucleic acids in 20–30 minutes at a constant temperature, greatly reducing the dependence on specialist equipment and technicians. RPA products are primarily detected through methods such as real-time fluorescence, gel electrophoresis, lateral flow assays (LFAs), and other techniques. Among these, LFAs allow for the rapid detection of amplification products within minutes through the visualization of results, offering convenient operation and low cost. Therefore, the combination of RPA with LFA technology has significant advantages and holds broad application prospects in point-of-care (POC) diagnostics, particularly in low-resource settings. Here, we focus on the principles of RPA combined with LFAs, their application to pathogen diagnosis, their main advantages and limitations, and some improvements in the methods.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The First Clinical Medical College of Guangxi Medical University, Nanning, China.
- Precision Joint Inspection Centre, The People's Hospital Guangxi Zhuang Autonomous Region and Guangxi Academy of Medical Sciences, Nanning, China.
- Graduate College, Guangxi University of Chinese Medicine, Nanning, China.
- School of Clinical Medicine, Guilin Medical University, Guilin, China.
- Department of Scientific Research, Affiliated Hospital of Chifeng University, Chifeng, China.
- Center for Reproductive Medicine and Genetics, The People's Hospital of Guangxi Zhuang Autonomous Region and Guangxi Academy of Medical Sciences, Nanning, China.
Zitieren
APA
Zhao, Y., Wei, Y., Ye, C., Cao, J., Zhou, X., Xie, M., Qing, J., & Chen, Z. (2024). Application of recombinase polymerase amplification with lateral flow assay to pathogen point-of-care diagnosis. Frontiers in Cellular and Infection Microbiology, 14. https://doi.org/10.3389/fcimb.2024.1475922
Vancouver
Zhao Y, Wei Y, Ye C, Cao J, Zhou X, Xie M, et al. Application of recombinase polymerase amplification with lateral flow assay to pathogen point-of-care diagnosis. Frontiers in Cellular and Infection Microbiology. 2024;14. doi:10.3389/fcimb.2024.1475922
BibTeX
@article{Zhao2024,
author = {Zhao, Yilian and Wei, Yan and Ye, Chao and Cao, Jinmeng and Zhou, Xiaoxing and Xie, Mengru and Qing, Jilin and Chen, Zhizhong},
title = {Application of recombinase polymerase amplification with lateral flow assay to pathogen point-of-care diagnosis},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2024},
volume = {14},
doi = {10.3389/fcimb.2024.1475922}
}
EUVIMED